| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Van Houte Hans is a Chief Financial Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $885K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 3,541 | $10.00 | $35,420.98 | -4.7% | +29.6% | +103.9% | |
| Dec 19, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 10,906 | $10.00 | $109,092.72 | -12.6% | +29.3% | +103.8% | |
| Oct 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,080 | $5.20 | $5,613.19 | -1.2% | +49.7% | +330.6% | |
| Jul 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,245 | $9.65 | $12,020.10 | -1.5% | -45.8% | +113.9% | |
| May 1, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 721 | $9.88 | $7,120.81 | -0.9% | -1.9% | +21.4% | |
| Jan 30, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 924 | $11.78 | $10,884.35 | -1.2% | -16.6% | -32.7% | |
| Oct 31, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 739 | $12.88 | $9,518.69 | -1.0% | -6.8% | -56.1% | |
| Aug 1, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 752 | $15.67 | $11,783.84 | -1.0% | -17.4% | -38.4% | |
| May 2, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 697 | $11.75 | $8,189.75 | -24.2% | +28.8% | -21.4% | |
| Feb 24, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 35,419 | $39.90 | $1,413,218.10 | -100% | - | - |